JT
John T. Treace bought $211K of TMCI stock
John T. Treace, Chief Executive Officer, 10% of Treace Medical Concepts, Inc. (TMCI), bought 52,317 shares of TMCI stock worth $211K, per an SEC Form 4 filed Jun 11, 2026.
It was an open-market purchase.
The trade happened on Jun 10, 2026, 1 day before it was made public.
TMCI has moved +1.9% since the trade date, from $4.23 to $4.31 (Nov 20, 2026 close).
- Traded
- Jun 10, 2026
- Disclosed
- Jun 11, 2026
- Filing delay
- 1 day
- Price since
- +1.9%
- Role
- Chief Executive Officer, 10%
- Source
- SEC Form 4